Deal Details
Follow-On Offering
Summary
Baird served as a co-manager of this offering.
About
Complete Genomics, Inc. (NASDAQ: GNOM) (“Complete Genomics” or the “Company”) recently completed a 6,325,000 share follow-on offering of common stock at a price of $12.50 per share. All shares offered were sold by the Company resulting in gross proceeds of approximately $79.1 million. The Company intends to use the net proceeds from the offering for capital expenditures to expand the sequencing and computing capacity in its Mountain View and Santa Clara leased facilities, to finance the further development of its sequencing technology and services, for sales and marketing activities and for working capital and other general corporate purposes.Complete Genomics is a complete human genome sequencing company that has developed and commercialized an innovative DNA sequencing platform. The Complete Genomics Analysis Platform (CGA™ Platform) combines Complete Genomics' proprietary human genome sequencing technology with its advanced informatics and data management software. The Company offers this innovative, end-to-end, outsourced solution as CGA™ Service, which provides customers with data that is immediately ready to be used for genome-based research.
For additional information about this transaction, please contact:
- Date
- May 2011
- Company
- Complete Genomics, Inc.
- Transaction
- M&A
- Sectors
- Healthcare
- Target Geography
- North America
Share
